500
Participants
Start Date
November 30, 2009
Primary Completion Date
February 29, 2012
Study Completion Date
February 29, 2012
HYCAMTIN
Observing patients on HYCAMTIN and other drugs for SCLC.
GSK Investigational Site, Ljubljana
GSK Investigational Site, Vienna
GSK Investigational Site, Mátraháza
GSK Investigational Site, Golnik
GSK Investigational Site, Salzburg
GSK Investigational Site, Székesfehérvár
GSK Investigational Site, Orbassano (TO)
GSK Investigational Site, Tallinn
GSK Investigational Site, Córdoba
GSK Investigational Site, Caen
GSK Investigational Site, Rozzano (MI)
GSK Investigational Site, Besançon
GSK Investigational Site, Leer
GSK Investigational Site, Madrid
GSK Investigational Site, Madrid
GSK Investigational Site, Pessac
GSK Investigational Site, Kassel
GSK Investigational Site, Immenhausen
GSK Investigational Site, Saint-Priest-en-Jarez
GSK Investigational Site, Velbert
GSK Investigational Site, Parma
GSK Investigational Site, Zaragoza
GSK Investigational Site, Cologne
GSK Investigational Site, Bonn
GSK Investigational Site, Lorient
GSK Investigational Site, Thessaloniki
GSK Investigational Site, Hemer
GSK Investigational Site, Wiesbaden
GSK Investigational Site, Perpignan
GSK Investigational Site, Strasbourg
GSK Investigational Site, Pierre-Bénite
GSK Investigational Site, Heraklion, Crete
GSK Investigational Site, Lecce
GSK Investigational Site, Paris
GSK Investigational Site, Munich
GSK Investigational Site, Draguignan
GSK Investigational Site, Créteil
GSK Investigational Site, Graz
GSK Investigational Site, Innsbruck
GSK Investigational Site, Brno
GSK Investigational Site, Pilsen
GSK Investigational Site, Athens
GSK Investigational Site, Sassari
GSK Investigational Site, Kaunas
GSK Investigational Site, Klaipėda
GSK Investigational Site, Vilnius
GSK Investigational Site, Vilnius
GSK Investigational Site, Amsterdam
GSK Investigational Site, Breda
GSK Investigational Site, Eindhoven
GSK Investigational Site, Groningen
GSK Investigational Site, Gorzów Wielkopolski
GSK Investigational Site, Głuchołazy
GSK Investigational Site, Krakow
GSK Investigational Site, Lodz
GSK Investigational Site, Lublin
GSK Investigational Site, Warsaw
GSK Investigational Site, Seongnam-si, Gyeonggi-do
GSK Investigational Site, Seoul
GSK Investigational Site, Suwon, Gyeonggi-do
GSK Investigational Site, Palma de Mallorca
Lead Sponsor
GlaxoSmithKline
INDUSTRY